Five hospital organizations, including the American Hospital Association (AHA) and 340B Health, have urged two US Courts of Appeals to uphold the 340B drug pricing requirement for pharmaceutical...
Safety-net hospitals have faced around $2.2 million in annualized losses due to pharmaceutical companies limiting 340B drug discounts at community and specialty pharmacies, a report from 340B Health...
Hospitals have seen stark increases in revenue generated from the 340B drug pricing program, but Massachusetts hospitals had low levels of charity care, indicating that the health systems are pocketing...
Safety-net hospitals have faced losses of up to $9 million due to a handful of drug companies limiting 340B discounts on prescription drugs dispensed through community pharmacies, according to a report...
Bristol Myers Squibb has notified safety-net hospitals participating in the 340B Drug Discount Program that it will only recognize two designated contract pharmacy locations per hospitals. The company...
The US Supreme Court recently announced that it will hear an ongoing debate over cuts to 340B drug payments to Medicare hospitals.
The case will be heard during the Supreme Court’s upcoming...
Leading industry groups representing hospitals and pharmacists have written a letter to new HHS Secretary Xavier Becerra asking him to take action against six major pharmaceutical companies that are...
Outpatient payments would decrease for the majority of hospitals if HHS reversed a controversial policy reducing 340B drug reimbursement, according to a new Avalere analysis.
The analysis examined...
The American Hospital Association (AHA), joined by member hospitals and other national organizations, have filed petitions asking the Supreme Court to reverse two appeals court decisions impacting...
New guidance from HHS has clarified that hospitals and other covered entities in the 340B Drug Pricing Program are entitled to discounts for covered outpatient drugs even if they use contract...
The American Hospital Association (AHA) and four other hospital organizations are suing HHS after the department failed to enforce 340B Drug Pricing Program requirements when major pharmaceutical...
According to the American Hospital Association (AHA), an appeals court has declined to reconsider two decisions from the summer, which upheld Medicare reimbursement cuts for 340B drugs and for...
The controversy surrounding the notorious 340B Drug Pricing Program continues with more than 1,100 hospitals now urging HHS to stop pharmaceutical companies from refusing discounts for drugs covered by...
The American Hospital Association (AHA) is demanding that five major pharmaceutical companies cease new efforts to curtail 340B drug discounts.
In the past couple of weeks, Merck, Eli Lilly, Sanofi,...
An appeals court recently ruled against hospital groups seeking to block a nearly 30 percent reduction in 340B hospital payments to hospitals participating in the federal drug discount program.
The...
